The slip
PARKINSON RECEIPTno. 8512
24 Oct 2026, 09:34 UTColigodendrocytes, braak
predictionLRRN1 in oligodendrocytes tracks Braak Lewy-body stage
registered7159073075f9624c
discovery+0.04 p=0.912 n=9
replication-0.13 p=0.732 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.04, p 0.912)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT61b0c86764c655098fae5718…
follows 85de2ea33f0d…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8512: LRRN1 in oligodendrocytes, braak
- power
- full sample -0.06 (p 0.800, n 18), 95% CI -0.52 to +0.42. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.02 (p 0.928, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.02 (p 0.928, n 18). could be the mix.
- skeptic
- leave-one-out range -0.23 to +0.06, sign flips 5; without severely affected donors -0.06 (p 0.800, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LRRN1 in oligodendrocytes.
case closed: nothing better to follow up.